With over 60 commercial occupiers on campus, in addition to the Babraham Institute and wider Babraham Research Campus teams, there are generally a number of roles being advertised at any one time. Details of current vacancies are listed below, click on the links to discover more about them and how to apply.
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), is the in-house CRUK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.
We are currently recruiting for two positions, a Principal Scientist and a Scientist, to join CRUK-TDL’s Discovery Bioscience Screening and Compound Profiling team to prosecute high-throughput screening (HTS).
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), is the in-house CRUK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.
We are currently recruiting for two positions, a Senior Scientist and a Scientist, to join CRUK-TDL’s Discovery Bioscience Screening and Compound Profiling team to characterise small molecules in vitro.
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), is the in-house CRUK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.
We are currently recruiting for Associate Scientists and Scientists to join our Target Validation and Disease Positioning group.
The purpose of the role is to undertake research within the Cell Line Development group to support the timely delivery of customer projects. The role will involve working as part of a small team, within the larger Cell Line Development group, in order to generate mammalian cell lines for the expression and manufacture of therapeutic proteins.
New Path Molecular specialises in the chemical synthesis of complex functional molecules using the cutting-edge techniques, methods and instrumentation developed in the laboratories of Prof Steve Ley at the University of Cambridge.
The purpose of this role is to develop chemical methodology with our collaborators in pharma and biotech to enable the synthesis of molecules with biological function.
PredictImmune is a spin-out from Cambridge University and is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis).
With continued growth, we are now seeking a Product Manager who will report into our Senior Marketing and Scientific Liaison and be responsible for providing comprehensive support across a broad spectrum of promotional marketing activities and strategic planning.
PredictImmune is a spin-out from Cambridge University and is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis).
With continued growth, we are now seeking a Scientist/Senior Scientist.
We are looking for a highly-motivated Scientist or Senior Scientist to join our Biomarker team at our Cambridge, UK-based facilities for 12 months to cover a period of maternity leave. Mission Therapeutics is ideally situated on the Babraham Research Campus near Cambridge, at the heart of Europe’s largest biotechnology cluster.
F-star develops novel bispecific antibodies using its Modular Antibody Technology, directed at improving the treatment of serious diseases, with a focus on immuno-oncology.
This role will work within the Assay Development team and will lead the design, development and optimisation of in vitro biological assays and establishment of Standard Operating Procedures and protocols.
F-star develops therapeutic bispecific antibodies using its Modular Antibody Technology, directed at improving the treatment of serious diseases, with a focus on immuno-oncology.
We are looking for a Scientist or Senior Scientist (depending on experience) to lead from the bench within the Assay Development team.
Mission Therapeutics is a drug discovery and development company focused on the inhibition of deubiquitylating (DUB) enzymes for treatment of diseases with high unmet need including rare mitochondrial disorders, cancer, inflammation, and neurodegeneration.
We are currently seeking a highly motivated Scientist or Senior Scientist to cover a period of maternity leave in the Biomarker team at our Cambridge, UK based facilities.
F-star develops therapeutic bispecific antibodies using its Modular Antibody Technology, directed at improving the treatment of serious diseases, with a focus on immuno-oncology.
The Senior Research Associate will undertake a lab-based role within the Drug Discovery group, accountable for designing and executing experiments and subsequent analysis, interpretation and reporting of the results.
F-star develops novel bispecific antibodies using its Modular Antibody Technology, directed at improving the treatment of serious diseases, with a focus on immuno-oncology.
Working within the Protein Sciences group, you will proactively contribute to the development and delivery of analytical capabilities to support our technology platform and mAb2 bispecific pipeline.
Kymab is an expanding biopharmaceutical company based at the Babraham Research Campus near Cambridge, UK. The company is engaged in the discovery and development of human monoclonal antibody therapeutics.
We are looking for a Senior Research Scientist to develop and qualify novel bioanalytical methods for immunogenicity testing, pharmacokinetics and soluble biomarkers as required to support the progress of Kymab therapeutic antibody candidates through pre-clinical and clinical development.
Kymab is an expanding biopharmaceutical company based at the Babraham Research Campus near Cambridge, UK. The company is engaged in the discovery and development of human monoclonal antibody therapeutics.
We have a new vacancy in our expanding Non-Clinical Development team for an experienced individual to take responsibility for the management of non-clinical Toxicology programmes to support progression of Kymab’s biopharmaceutical drug candidates into the clinic and beyond.
Kymab is an expanding biopharmaceutical company based at the Babraham Research Campus near Cambridge, UK. The company is engaged in the discovery and development of human monoclonal antibody therapeutics.
We are now looking to recruit a permanent Director of Pharmacology & Translational Sciences within our Immuno-Oncology (IO) Therapy Area.
Kymab is a leading biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary Kymouse™ antibody platform.
We are seeking to augment our existing project management team by recruiting an experienced project management professional who will take responsibility for project management of a sub-set of Kymab’s antibody development programmes.
Kymab is a leading biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary Kymouse™ antibody platform.
The Infectious Diseases & Vaccine group is expanding and are looking to recruit a PhD-qualified Research Scientist. You will be working as part of a team developing antibody-based therapies for bacterial infections of global importance, including nosocomial infections related to antibiotic resistance.
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), is the in-house CRUK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.
This role gives you the exciting opportunity to play an integral part in the TDL team, working alongside our scientists to progress novel cancer targets towards patient benefit.
Talisman Therapeutics Ltd is a cutting-edge drug discovery company based in Cambridge, UK. We are currently seeking to recruit an ambitious, enthusiastic, PhD-level scientist to join our expanding team and play a key role in the delivery of both internal and collaborative drug discovery projects.
Crescendo Biologics Ltd is recruiting for a Senior Scientist within the Assay Development team. The role will develop and run a variety of assays to select and characterise the in vitro functional activity of Crescendo’s Humabody drug candidates, with an emphasis on oncology and in particular immuno-oncology providing both strategic and technical support.
CamPhos Therapeutics is an emerging drug discovery and development company, which is backed by a leading European investor.
We are looking for a talented cellular pharmacologist Principal / Senior Scientist to join our team.
CamPhos Therapeutics is an emerging drug discovery and development company, which is backed by a leading European investor.
We are looking for a talented assay development and screening Principal / Senior Scientist to join our team.
(+44) 1223 496 000
info@babraham.co.uk
Babraham Bioscience Technologies Ltd
Babraham Research Campus
Cambridge
CB22 3AT, United Kingdom
Limewash
01223 813 557
info@limewash.co.uk
